Kareem Saad

Kareem Saad

Chief Transformation OfficeratGeneDx Holdings· In proxies 2022–2023

Pay in FY2023-43% from the year before · GeneDx Holdings stock -68.4% the same year

Kareem Saad was paid $1.2M in FY2023 (Dec), down 43%. GeneDx Holdings stock fell 68.4% that year.

Pay$100 in the stock at the end of FY21 → $2
Pay is from the Summary Compensation Table of each GeneDx Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. GeneDx HoldingsPublic company · 4 yr
    • Chief Transformation Officer2022 – Present · 4 yrStock in role -56%

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?